Prelude Capital Management, LLC Lannett CO Inc Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.75 - $7.13 $42,682 - $52,925	-7,423 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.43 - $9.86 $47,729 - $73,190	7,423 New	7,423 $54,000
Q3 2019 Nov 14, 2019	SELL	$5.58 - $14.47 $104,346 - $270,589	-18,700 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.22 - $9.08 $21,402 - $37,228	4,100 Added 28.08%	18,700 $113,000
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $78,110 - $143,372	14,600 New	14,600 $115,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $9,975 - $30,450	-2,100 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $27,930 - $36,645	2,100 New	2,100 $29,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.